IL10 and neoplasm: TAMs remodel the TME by releasing the inhibitory cytokines, including TGF-β and IL-10, and expressing immune checkpoint ligands to inhibit infiltration and anti-tumor activity of other immune cells, especially cytotoxic T cells.